Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M458Revenue $M156Net Margin (%)-46.5Z-Score0.7
Enterprise Value $M406EPS $-1.0Operating Margin %-20.7F-Score4
P/E(ttm))0Cash Flow Per Share $0.7Pre-tax Margin (%)-25.0Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %0Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow16.2y-y EBITDA Growth Rate %0ROA % (ttm)-17.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-29.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.8ROI % (ttm)5.7Gross Margin Increase y-yY

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJohn Burbank 2012-12-31 Sold Out -0.13%$10.64 - $12.31
($11.39)
$ 6.97-39%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 6.97-39%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 6.97-39%Sold Out0
SPPIJohn Burbank 2012-09-30 Buy 0.13%$11.6 - $17.05
($13.85)
$ 6.97-50%New holding, 250000 sh.250,000
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 6.97-50%New holding, 19901 sh.19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-39.39view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-43.1view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-38.97view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-38.26view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-40.17view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-36.35view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-37.15view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-44.24view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-40.93view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-41.92view

Press Releases about SPPI :

    Quarterly/Annual Reports about SPPI:

    News about SPPI:

    Articles On GuruFocus.com
    http://seekingalpha. Aug 14 2012 
    Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
    5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
    Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
    Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
    Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
    Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
    Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for... Dec 26 2014
    Spectrum submits blood-cancer drug for FDA approval Dec 26 2014
    Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™... Dec 26 2014
    Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™... Dec 26 2014
    7:00 am Spectrum Pharma files a new drug application with the FDA for captisol-enabled Melphalan Dec 26 2014
    Market's most shorted stocks Dec 10 2014
    Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society... Dec 05 2014
    Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society... Dec 05 2014
    SPECTRUM PHARMACEUTICALS INC Financials Nov 18 2014
    Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind Nov 14 2014
    10-Q for Spectrum Pharmaceuticals, Inc. Nov 12 2014
    Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare... Nov 12 2014
    Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare... Nov 12 2014
    Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare... Nov 12 2014
    SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Spectrum Pharma posts 3Q loss Nov 07 2014
    Spectrum Pharma posts 3Q loss Nov 07 2014
    Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9... Nov 06 2014
    Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Nov 06 2014
    SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK